| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |